nach oben

Quality of Life Research

Erschienen in:

31.03.2017

Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes

verfasst von: Fatima Al Sayah, Weiyu Qiu, Feng Xie, Jeffrey A. Johnson

Erschienen in: Quality of Life Research | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To explore the comparative performance including discriminative and longitudinal validity of EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.

Methods

Data from an on-going cohort study of adults with type 2 diabetes in Alberta, Canada, were used. Known-groups approach was used to examine discriminative validity. Correlation and agreement indices and scatter and Bland–Altman plots were used to examine the relationship between the two measures. Longitudinal validity was explored using Wilcoxon signed-rank test, effect size, and standardized response mean.

Results

In 1832 participants at baseline (age 64.3, standard deviation 10.6 years; 45% female), median EQ-5D-5L score was 0.85 [interquartile range (IQR) 0.17], and floor and ceiling effects of 0.1 and 16.1%, respectively; median SF-6D score was 0.72 (IQR 0.24), and floor and ceiling effects of 0.1 and 3.2%, respectively. EQ-5D-5L and SF-6D index scores were significantly correlated with an overall Spearman correlation coefficient of 0.73, and an ICC of 0.62 (95% CI 0.42–0.74). Both EQ-5D-5L and SF-6D scores demonstrated statistically significant differences in self-reported chronic conditions, depressive symptoms, and diabetes-related distress, and were able to detect changes in depressive symptoms and diabetes distress across all change groups.

Conclusions

Both EQ-5D-5L and SF-6D index scores provide valid measurement in this patient population. Considerable overlap between the measures means it is not necessary to include both in surveys, however, the advantages and disadvantages of each should be considered.

Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice, 87(1), 4–14.CrossRefPubMed

Egede, L. E. (2004). Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care, 27(2), 421–428.CrossRefPubMed

Gregg, E. W., Mangione, C. M., Cauley, J. A., Thompson, T. J., Schwartz, A. V., Ensrud, K. E., et al. (2002). Diabetes and incidence of functional disability in older women. Diabetes Care, 25(1), 61–67.CrossRefPubMed

Maddigan, S., Feeny, D., & Johnson, J. A. (2005). Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Quality of Life Research, 14(5), 1311–1320.CrossRefPubMed

Marrero, D., Pan, Q., Barrett-Connor, E., de Groot, M., Zhang, P., Percy, C., et al. (2014). Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: The Diabetes Prevention Program outcomes study. Quality of Life Research, 23(1), 75–88.CrossRefPubMed

Maddigan, S. L., Feeny, D. H., Majumdar, S. R., Farris, K. B., & Johnson, J. A. (2006). Understanding the determinants of health for people with type 2 diabetes. American Journal of Public Health, 96(9), 1649–1655.CrossRefPubMedPubMedCentral

Drummond, M. (2001). Introducing economic and quality of life measurements into clinical trials. Annals of Medicine, 33, 344–349.CrossRefPubMed

Drummond, M. F., O’Brien, B. J., Stoddart, G. L., & Torrance, G. W. (1997). Methods for the economic evaluation of health care programmes (2nd ed.). Oxford: Oxford University Press.

Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: Bibliographic study of patient assessed health outcome measures. BMJ, 324(7351), 1471.CrossRef

10.

Xie, F., Pullenayegum, E., Gaebel, K., Bansback, N., Bryan, B., Ohinmaa, A., et al. (2016). A time trade-off-derived value set of the EQ-5D-5L for Canada. Medical Care, 54(1), 98–105.CrossRefPubMed

11.

Brazier, J. E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42(9), 851–859.CrossRefPubMed

12.

Whitehurst, D. G., Bryan, S., & Lewis, M. (2011). Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores. Medical Decision Making, 31(6), E34–E44.CrossRefPubMed

13.

Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13(9), 873–884.CrossRefPubMed

14.

De Smedt, D., Clays, E., Annemans, L., & De Bacquer, D. (2014). EQ-5D versus SF-12 in coronary patients: Are they interchangeable? Value in Health, 17(1), 84–89.CrossRefPubMed

15.

Kontodimopoulos, N., Pappa, E., Chadjiapostolou, Z., Arvanitaki, E., Papadopoulos, A. A., & Niakas, D. (2012). Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications. The European Journal of Health Economics, 13(1), 111–120.CrossRefPubMed

16.

Kontodimopoulos, N., Pappa, E., Papadopoulos, A. A., Tountas, Y., & Niakas, D. (2009). Comparing SF-6D and EQ-5D utilities across groups differing in health status. Quality of Life Research, 18(1), 87–97.CrossRefPubMed

17.

Mulhern, B., & Meadows, K. (2014). The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes. Health and Quality of Life Outcomes, 12, 42.CrossRefPubMedPubMedCentral

18.

Obradovic, M., Lal, A., & Liedgens, H. (2013). Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain. Health and Quality of Life Outcomes, 11, 110.CrossRefPubMedPubMedCentral

19.

Petrou, S., & Hockley, C. (2005). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189.CrossRefPubMed

20.

Pickard, A. S., Johnson, J. A., & Feeny, D. H. (2005). Responsiveness of generic health-related quality of life measures in stroke. Quality of Life Research, 14(1), 207–219.CrossRefPubMed

21.

van Stel, H. F., & Buskens, E. (2006). Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease. Health and Quality of Life Outcomes, 4, 20.CrossRefPubMedPubMedCentral

22.

Wu, J., Han, Y., Zhao, F. L., Zhou, J., Chen, Z., & Sun, H. (2014). Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. Health and Quality of Life Outcomes, 12, 156.CrossRefPubMedPubMedCentral

23.

Xie, F., Li, S. C., Luo, N., Lo, N. N., Yeo, S. J., Yang, K. Y., et al. (2007). Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement. Arthritis and Rheumatism, 57(6), 1043–1049.CrossRefPubMed

24.

Agborsangaya, C. B., Lahtinen, M., Cooke, T., Johnson, J. A. (2014). Comparing the EQ-5D 3L and 5L: Measurement properties and association with chronic conditions and multimorbidity in the general population. Health and Quality of Life Outcomes, 12, 74.CrossRefPubMedPubMedCentral

25.

Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22(7), 1717–1727.CrossRefPubMed

26.

Al Sayah, F., Majumdar, S. R., Soprovich, A., Wozniak, L., Johnson, S. T., Qiu, W., et al. (2015). The Alberta’s Caring for Diabetes (ABCD) Study: Rationale, design and baseline characteristics of a prospective cohort of adults with type 2 diabetes. Canadian Journal of Diabetes, 39(Suppl 3), S113–S119.CrossRefPubMed

27.

Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736.CrossRefPubMedPubMedCentral

28.

Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173.CrossRefPubMed

29.

Manea, L., Gilbody, S., & McMillan, D. (2012). Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. Canadian Medical Association Journal, 184(3), E191–E196.CrossRefPubMedPubMedCentral

30.

McGuire, B. E., Morrison, T. G., Hermanns, N., Skovlund, S., Eldrup, E., Gagliardino, J., et al. (2010). Short-form measures of diabetes-related emotional distress: The Problem Areas in Diabetes Scale (PAID)-5 and PAID-1. Diabetologia, 53(1), 66–69.CrossRefPubMed

31.

Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592.PubMed

32.

Fritz, C. O., Morris, P. E., & Richler, J. J. (2012). Effect size estimates: Current use, calculations, and interpretation. Journal of Experimental Psychology: General, 141(1), 2–18.CrossRef

33.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates Inc.

34.

Mukaka, M. (2012). A guide to appropriate use of correlation coefficient in medical research. Malawi Medical Journal, 24(3), 69–71.PubMedPubMedCentral

35.

Cicchetti, D. V. (1994). Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychological Assessment, 6(4), 284–290.CrossRef

36.

Giavarina, D. (2015). Understanding Bland Altman analysis. Biochemia Medica, 25(2), 141–151.CrossRefPubMedPubMedCentral

37.

Biering, K., Hjollund, N. H., & Frydenberg, M. (2015). Using multiple imputation to deal with missing data and attrition in longitudinal studies with repeated measures of patient-reported outcomes. Clinical Epidemiology, 16(7), 91–106.CrossRef

38.

Revicki DA. (2002). Analyzing longitudinal health-related quality of life data: Missing data and imputation methods. In: M. Mesbah, B. F. Cole, M. L. Ting Lee (Eds.). Statistical methods for quality of life studies: Design, measurements and analysis (1st ed., pp 103–112). New York: Springer.CrossRef

39.

Royston, P., & White, I. R. (2011) Multiple Imputation by Chained Equations (MICE): Implementation in Stata. Journal of Statistical Software, 45(4), 1–20.CrossRef

40.

Wee, H. L., Machin, D., Loke, W. C., Li, S. C., Cheung, Y. B., Luo, N., et al. (2007). Assessing differences in utility scores: A comparison of four widely used preference-based instruments. Value in Health, 10(4), 256–265.CrossRefPubMed

41.

Yordanova, S., Petkova, V., Petrova, G., Dimitrov, M., Naseva, E., Dimitrova, M., et al. (2014). Comparison of health-related quality-of-life measurement instruments in diabetic patients. Biotechnology and Biotechnological Equipment, 28(4), 769–774.CrossRefPubMedPubMedCentral

42.

Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13, 14.CrossRefPubMedPubMedCentral

43.

Brazier, J., Deverill, M., Green, C., Harper, R., & Booth, A. (1999). A review of the use of health status measures in economic evaluation. Health Technology Assessment, 3(9), 1–164.

44.

Bryan, S., & Longworth, L. (2005). Measuring health-related utility: Why the disparity between EQ-5D and SF-6D? The European Journal of Health Economics, 6(3), 253–260.CrossRefPubMed

Titel: Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes
verfasst von: Fatima Al Sayah
Weiyu Qiu
Feng Xie
Jeffrey A. Johnson
Publikationsdatum: 31.03.2017
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 8/2017
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-017-1559-8

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Systematic review of caregiver responses for patient health-related quality of life in adult cancer care

A systematic review of measurement properties of patient-reported outcome measures for use in patients with foot or ankle diseases

Health-related quality of life in patients receiving long-term opioid therapy: a systematic review with meta-analysis

An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D

Effect of a comprehensive health education program on pre-hospital delay intentions in high-risk stroke population and caregivers

Predictors of the course of quality of life during therapy in women with primary breast cancer